We’re pleased to share our latest learning opportunities, including newly added training courses and upcoming webinars designed to support professionals across the life sciences sector. Whether you’re looking to build new skills or deepen your expertise, explore the options below and find the right learning opportunity for you.
________________________________________________
One Nucleus Training
A podcast for the rising stars of the start-up community
Marks & Clerk presents a podcast series created specifically for the start-up community, helping founders understand the importance of embedding intellectual property (IP) into their business strategy from day one.
BOSTON, MA and LONDON, UK – March 11, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search for Syntis Bio, Inc. and is pleased to announce the placement of David Rosenbaum, Ph.D. as Chief Development Officer (CDO).
BioIgnite: Sparking Growth Through Collaboration
Bionow's BioIgnite conference is back for 2026! Bringing together industry and academia to explore emerging innovation, sector initiatives and funding opportunities across life sciences, the bespoke agenda creates a focused environment for insight, discussion and connection.
Why Attend?
Connecting Investors and Innovators in Life Sciences
Whether you're looking to invest in the next breakthrough in life sciences or seeking funding opportunities for your business, BioCap is THE date for your diary!
BioCap offers three exciting opportunities for investors and businesses to connect:
Sandwich, UK - 9 March 2026: SignaCor Therapeutics has been named the winner of Discovery Park's startup growth programme for innovations in cardiovascular health, securing £250k in funding from venture capital firm Zinc. This investment forms part of a £1M seed round expected to close in April.
Who we are
We are currently looking for a Health and Safety Consultant to join our small team at Health & Safety Works.
Our team is based in East Anglia, and all consultants work from home. You may however need to travel further afield.
What to Expect at the 8th T-Cell Engager Therapeutics Summit?
For over 30 years, UCLB has built a sustained engine of commercial success, turning exceptional UCL research into ventures and licensing deals across every discipline.
The UCL 2026 Impact Report demonstrates how this work is having real-world impact, from changing patients’ lives with new personalised treatments for leukaemia, to making businesses more efficient with the use of AI tools, to empowering communities to have their voices heard with data and maps.
Are you passionate about making life science life changing and delivering impact for patients? We want to hear from you.
The Scientist, Antibody Discovery role will be focused on screening and subsequent characterisation of monoclonal antibodies using a range of assay technologies.